Paper41018951
Pharmacologic activation of Δ133p53α reduces cellular senescence in progeria patients-derived cells.
Joruiz SM and 6 others. Aging Pathobiol Ther, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Pharmacologic activation of Δ133p53α reduces cellular senescence in progeria patients-derived cells. Papers, record 41018951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41018951
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacologic activation of Δ133p53α reduces cellular senescence in progeria patients-derived cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ZIA BC011496 | Intramural NIH HHS | United States | ZIABC011496 | PubMed | NIH RePORTER |
| ZIA TR000052 | Intramural NIH HHS | United States | ZIATR000052 | PubMed | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 40766643 |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1552940 | Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. | Nature | 1992 | https://conductscience.org/library/papers/1552940 | PubMed |
| 2 | 29970881 | Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29970881 | PubMed |
| 3 | 33818291 | Astrocyte senescence and SASP in neurodegeneration: tau joins the loop. | Cell Cycle | 2021 | https://conductscience.org/library/papers/33818291 | PubMed |
| 4 | 39121846 | Guidelines for minimal information on cellular senescence experimentation in vivo. | Cell | 2024 | https://conductscience.org/library/papers/39121846 | PubMed |
| 5 | 16651429 | Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. | Cancer Res | 2006 | https://conductscience.org/library/papers/16651429 | PubMed |
| 6 | 28362428 | Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells. | Cell Death Differ | 2017 | https://conductscience.org/library/papers/28362428 | PubMed |
| 7 | 26330290 | Hutchinson-Gilford progeria syndrome as a model for vascular aging. | Biogerontology | 2016 | https://conductscience.org/library/papers/26330290 | PubMed |
| 8 | 17457049 | p53: guardian of the genome and policeman of the oncogenes. | Cell Cycle | 2007 | https://conductscience.org/library/papers/17457049 | PubMed |
| 9 | 30615147 | Radiation-induced astrocyte senescence is rescued by Δ133p53. | Neuro Oncol | 2019 | https://conductscience.org/library/papers/30615147 | PubMed |
| 10 | 16645051 | Lamin A-dependent nuclear defects in human aging. | Science | 2006 | https://conductscience.org/library/papers/16645051 | PubMed |
| 11 | 35656110 | Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets. | Aging Dis | 2022 | https://conductscience.org/library/papers/35656110 | PubMed |
| 12 | 36980874 | The Molecular and Cellular Basis of Hutchinson-Gilford Progeria Syndrome and Potential Treatments. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/36980874 | PubMed |
| 13 | 23150434 | Detecting p53 isoforms at protein level. | Methods Mol Biol | 2013 | https://conductscience.org/library/papers/23150434 | PubMed |
| 14 | 18982914 | Model of human aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromes. | Clin Interv Aging | 2008 | https://conductscience.org/library/papers/18982914 | PubMed |
| 15 | 29276415 | CRTH2 antagonists in asthma: current perspectives. | Clin Pharmacol | 2017 | https://conductscience.org/library/papers/29276415 | PubMed |
| 16 | 25144556 | Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence. | Nat Commun | 2014 | https://conductscience.org/library/papers/25144556 | PubMed |
| 17 | 38408246 | Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38408246 | PubMed |
| 18 | 27104929 | p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. | Cell Death Differ | 2016 | https://conductscience.org/library/papers/27104929 | PubMed |
| 19 | 11313961 | Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. | Oncogene | 2001 | https://conductscience.org/library/papers/11313961 | PubMed |
| 20 | 21570383 | Radiosensitization by celastrol is mediated by modification of antioxidant thiol molecules. | Chem Biol Interact | 2011 | https://conductscience.org/library/papers/21570383 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769509 | The senescence-inhibitory p53 isoform Δ133p53α represses the proinflammatory chemokine CXCL10 in progeria model mice and naturally aged mice. | Geromedicine | 2026 | https://conductscience.org/library/papers/42769509 | PubMed |
| 41509461 | Senescence-inhibitory Δ133p53α counteracts accelerated ageing and mortality. | bioRxiv | 2026 | https://conductscience.org/library/papers/41509461 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41018951
GET https://conductscience.org/api/papers/v1/41018951/references?page=2